标题
Lipoxin Mimetics and the Resolution of Inflammation
作者
关键词
-
出版物
Annual Review of Pharmacology and Toxicology
Volume 63, Issue 1, Pages 429-448
出版商
Annual Reviews
发表日期
2023-01-21
DOI
10.1146/annurev-pharmtox-051921-085407
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Inflammation in obesity, diabetes, and related disorders
- (2022) Theresa V. Rohm et al. IMMUNITY
- FPR2 DNA Aptamers for Targeted Therapy of Wound Repair
- (2022) María del Carmen de Arriba et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Peroxisome-generated succinate induces lipid accumulation and oxidative stress in the kidneys of diabetic mice
- (2022) Yaoqing Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Long-term culture-expanded alveolar macrophages restore their full epigenetic identity after transfer in vivo
- (2022) Sethuraman Subramanian et al. NATURE IMMUNOLOGY
- Formyl peptide receptor 2 and heart disease
- (2022) John A. Lupisella et al. SEMINARS IN IMMUNOLOGY
- Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2
- (2022) Youwen Zhuang et al. Nature Communications
- Structural basis of FPR2 in recognition of Aβ42 and neuroprotection by humanin
- (2022) Ya Zhu et al. Nature Communications
- Therapeutic potential of the FPR2/ALX agonist AT-01-KG in the resolution of articular inflammation
- (2021) Izabela Galvão et al. PHARMACOLOGICAL RESEARCH
- Recent advances in the design and development of formyl peptide receptor 2 (FPR2/ALX) agonists as pro-resolving agents with diverse therapeutic potential
- (2021) Monika Maciuszek et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Annexin A1 alleviates kidney injury by promoting the resolution of inflammation in diabetic nephropathy
- (2021) Liang Wu et al. KIDNEY INTERNATIONAL
- Targeting inflammation in atherosclerosis — from experimental insights to the clinic
- (2021) Oliver Soehnlein et al. NATURE REVIEWS DRUG DISCOVERY
- Resolution-Based Therapies: The Potential of Lipoxins to Treat Human Diseases
- (2021) Rafael I. Jaén et al. Frontiers in Immunology
- The attenuation of diabetic nephropathy by annexin A1 via regulation of lipid metabolism through AMPK/PPARα/CPT1b pathway
- (2021) Liang Wu et al. DIABETES
- Asymmetric Synthesis and Biological Screening of Quinoxaline-Containing Synthetic Lipoxin A4 Mimetics (QNX-sLXms)
- (2021) Monica de Gaetano et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function
- (2021) Eoin Brennan et al. Nature Reviews Nephrology
- Safety and Preliminary Efficacy of a Novel Host-Modulatory Therapy for Reducing Gingival Inflammation
- (2021) Hatice Hasturk et al. Frontiers in Immunology
- Selective FPR2 Agonism Promotes a Proresolution Macrophage Phenotype and Improves Cardiac Structure-Function Post Myocardial Infarction
- (2021) Ricardo A. García et al. JACC-Basic to Translational Science
- Structural basis of ligand binding modes at the human formyl peptide receptor 2
- (2020) Tong Chen et al. Nature Communications
- Discovery of BMS-986235/LAR-1219: A Potent Formyl Peptide Receptor 2 (FPR2) Selective Agonist for the Prevention of Heart Failure
- (2020) Yoshikazu Asahina et al. JOURNAL OF MEDICINAL CHEMISTRY
- BML‐111 treatment prevents cardiac apoptosis and oxidative stress in a mouse model of autoimmune myocarditis
- (2020) Rafael I. Jaén et al. FASEB JOURNAL
- Biased allosteric modulation of formyl peptide receptor 2 leads to distinct receptor conformational states for pro- and anti-inflammatory signaling
- (2020) Shuo Zhang et al. PHARMACOLOGICAL RESEARCH
- Resolvin D1 supports skeletal myofiber regeneration via actions on myeloid and muscle stem cells
- (2020) James F. Markworth et al. JCI Insight
- Formyl peptide receptor type 2 agonists to kick‐start resolution pharmacology
- (2020) Mauro Perretti et al. BRITISH JOURNAL OF PHARMACOLOGY
- Kidney Single-Cell Atlas Reveals Myeloid Heterogeneity in Progression and Regression of Kidney Disease
- (2020) Bryan R. Conway et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Atlas of Inflammation Resolution (AIR)
- (2020) Charles N. Serhan et al. MOLECULAR ASPECTS OF MEDICINE
- LXA4-FPR2 signaling regulates radiation-induced pulmonary fibrosis via crosstalk with TGF-β/Smad signaling
- (2020) Hyunjung Kim et al. Cell Death & Disease
- Is Resolution the End of Inflammation?
- (2019) Karen T. Feehan et al. TRENDS IN MOLECULAR MEDICINE
- Macrophages: versatile players in renal inflammation and fibrosis
- (2019) Patrick Ming-Kuen Tang et al. Nature Reviews Nephrology
- Leukocytes from obese individuals exhibit an impaired SPM signature
- (2019) Cristina López-Vicario et al. FASEB JOURNAL
- Lipid mediators in immune regulation and resolution
- (2019) Derek W. Gilroy et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines
- (2019) Yihua Bai et al. MEDICAL SCIENCE MONITOR
- Functional and signaling characterization of the neutrophil FPR2 selective agonist Act-389949
- (2019) Simon Lind et al. BIOCHEMICAL PHARMACOLOGY
- Specialized pro-resolving mediators in diabetes: novel therapeutic strategies
- (2019) Eoin P. Brennan et al. CLINICAL SCIENCE
- Safety profile of autologous macrophage therapy for liver cirrhosis
- (2019) Francesca Moroni et al. NATURE MEDICINE
- Formyl peptide receptor 2 regulates monocyte recruitment to promote intestinal mucosal wound repair
- (2019) Dorothee Birkl et al. FASEB JOURNAL
- The role of non-resolving inflammation in atherosclerosis
- (2018) Canan Kasikara et al. JOURNAL OF CLINICAL INVESTIGATION
- Lipoxins Regulate the Early Growth Response–1 Network and Reverse Diabetic Kidney Disease
- (2018) Eoin P. Brennan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Endocycle-related tubular cell hypertrophy and progenitor proliferation recover renal function after acute kidney injury
- (2018) Elena Lazzeri et al. Nature Communications
- Lipoxin A4 Attenuates the Inflammatory Response in Stem Cells of the Apical Papilla via ALX/FPR2
- (2018) A. Gaudin et al. Scientific Reports
- Lipoxins Protect Against Inflammation in Diabetes-Associated Atherosclerosis
- (2018) E. P. Brennan et al. DIABETES
- Mechanisms of signalling and biased agonism in G protein-coupled receptors
- (2018) Denise Wootten et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Resolution of chronic inflammatory disease: universal and tissue-specific concepts
- (2018) Georg Schett et al. Nature Communications
- Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A4 mimetics (sLXms)
- (2018) Monica de Gaetano et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology
- (2017) Charles N. Serhan MOLECULAR ASPECTS OF MEDICINE
- Immune resolution mechanisms in inflammatory arthritis
- (2017) Mauro Perretti et al. Nature Reviews Rheumatology
- Pilot application of lipoxin A4 analog and lipoxin A4 receptor agonist in asthmatic children with acute episodes
- (2017) Xia Kong et al. Experimental and Therapeutic Medicine
- Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice
- (2017) Cheng Xue Qin et al. Nature Communications
- Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2/ALX agonist ACT-389949
- (2016) Anna K. Stalder et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Lipoxin A4 augments host defense in sepsis and reduces Pseudomonas aeruginosa virulence through quorum sensing inhibition
- (2016) Benedict Wu et al. FASEB JOURNAL
- Highly Dynamic Transcriptional Signature of Distinct Macrophage Subsets during Sterile Inflammation, Resolution, and Tissue Repair
- (2016) Tamas Varga et al. JOURNAL OF IMMUNOLOGY
- Resolution of inflammation: a new therapeutic frontier
- (2016) James N. Fullerton et al. NATURE REVIEWS DRUG DISCOVERY
- An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques
- (2016) Gabrielle Fredman et al. Nature Communications
- Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease
- (2015) Emma Börgeson et al. Cell Metabolism
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins
- (2015) Eleonora Cianci et al. Stem Cells Translational Medicine
- Reduced 15-lipoxygenase 2 and lipoxin A4/leukotriene B4 ratio in children with cystic fibrosis
- (2014) F. C. Ringholz et al. EUROPEAN RESPIRATORY JOURNAL
- Pro-resolving lipid mediators are leads for resolution physiology
- (2014) Charles N. Serhan NATURE
- Immune system modulation of kidney regeneration—mechanisms and implications
- (2014) Hans-Joachim Anders Nature Reviews Nephrology
- Transcellular biosynthesis of eicosanoids
- (2014) Angelo Sala et al. Pharmacological Reports
- Pulmonary Antifibrotic Mechanisms Aspirin-Triggered Lipoxin A4Synthetic Analog
- (2013) Rafael F. Guilherme et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Impaired Local Production of Proresolving Lipid Mediators in Obesity and 17-HDHA as a Potential Treatment for Obesity-Associated Inflammation
- (2013) A. Neuhofer et al. DIABETES
- Lipoxin A4modulates adaptive immunity by decreasing memory B-cell responses via an ALX/FPR2-dependent mechanism
- (2013) Sesquile Ramon et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Lipoxins Attenuate Renal Fibrosis by Inducing let-7c and Suppressing TGF R1
- (2013) E. P. Brennan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Lipoxin A4-Induced Heme Oxygenase-1 Protects Cardiomyocytes against Hypoxia/Reoxygenation Injury via p38 MAPK Activation and Nrf2/ARE Complex
- (2013) Xiao-Qing Chen et al. PLoS One
- Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses
- (2013) S. N. Cooray et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and safety of 15(R/S)-methyl-lipoxin A4in topical treatment of infantile eczema
- (2012) S.-H. Wu et al. BRITISH JOURNAL OF DERMATOLOGY
- Lipoxin A4 inhibits platelet-activating factor inflammatory response and stimulates corneal wound healing of injuries that compromise the stroma
- (2012) Azucena Kakazu et al. EXPERIMENTAL EYE RESEARCH
- Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis
- (2012) P. Ramachandran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lipoxin A4 and benzo-lipoxin A4 attenuate experimental renal fibrosis
- (2011) Emma Börgeson et al. FASEB JOURNAL
- Specialized pro-resolving lipid mediators in the inflammatory response: An update
- (2010) Gerard Bannenberg et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Synthesis and Biological Evaluation of Pyridine-Containing Lipoxin A4Analogues
- (2010) Colm D. Duffy et al. ChemMedChem
- Lipoxins: regulators of resolution
- (2010) Aidan Ryan et al. CURRENT OPINION IN PHARMACOLOGY
- FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis
- (2010) Paola Maderna et al. FASEB JOURNAL
- Anti-Inflammatory Role of the Murine Formyl-Peptide Receptor 2: Ligand-Specific Effects on Leukocyte Responses and Experimental Inflammation
- (2010) Neil Dufton et al. JOURNAL OF IMMUNOLOGY
- Resolvin D1 binds human phagocytes with evidence for proresolving receptors
- (2010) S. Krishnamoorthy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Macrophage Wnt7b is critical for kidney repair and regeneration
- (2010) S.-L. Lin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 15-Epi-lipoxin A4Inhibits Myeloperoxidase Signaling and Enhances Resolution of Acute Lung Injury
- (2009) Driss El Kebir et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Lipoxins: resolutionary road
- (2009) Paola Maderna et al. BRITISH JOURNAL OF PHARMACOLOGY
- ATLa, an Aspirin-Triggered Lipoxin A4 Synthetic Analog, Prevents the Inflammatory and Fibrotic Effects of Bleomycin-Induced Pulmonary Fibrosis
- (2009) V. Martins et al. JOURNAL OF IMMUNOLOGY
- Lipoxin A4: Anti-Inflammatory and Anti-Angiogenic Impact on Endothelial Cells
- (2009) N. Baker et al. JOURNAL OF IMMUNOLOGY
- International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
- (2009) R. D. Ye et al. PHARMACOLOGICAL REVIEWS
- Anti-inflammatory and pro-resolving properties of benzo-lipoxin A4 analogs
- (2009) Yee-Ping Sun et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Airway Lipoxin A4Generation and Lipoxin A4Receptor Expression Are Decreased in Severe Asthma
- (2008) Anna Planagumà et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Design and synthesis of benzo-lipoxin A4 analogs with enhanced stability and potent anti-inflammatory properties
- (2008) Nicos A. Petasis et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- ATL-1, an analogue of aspirin-triggered lipoxin A4, is a potent inhibitor of several steps in angiogenesis induced by vascular endothelial growth factor
- (2008) P F T Cezar-de-Mello et al. BRITISH JOURNAL OF PHARMACOLOGY
- Origin and physiological roles of inflammation
- (2008) Ruslan Medzhitov NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now